Supreme Pharmaceuticals Appoints Lawyer John Fowler As President And Director

Dec. 19, 2014 3:44 PM ETSPRWF
Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Short Only

Contributor Since 2009

Proactiveinvestors is a leading multi-media news organisation, investor portal and events management business with offices in New York, Sydney, Toronto, Frankfurt and London. Proactiveinvestors operates five financial websites in four languages providing breaking news, comment and analysis on hundreds of listed companies across the globe daily. We are one of the fastest growing financial media portals in the world. The group also operates hugely successful “investor forums” where three or four companies present to an audience of high net sophisticated investors, fund managers, hedge funds, private client brokers and analysts. Ian Mclelland founded Proactiveinvestors in 2006 as a way to channel his own views on companies small and mid-cap public companies. What started as a hobby quickly turned into a full time job as the website's readership exploded. One2One forums were added later in 2006, and within two years the company had expanded its operations into Canada and Australia. In 2009 the company expanded into Germany and finally into the US in 2010. Proactiveinvestors is now one of the fastest growing global financial media organizations in the world receiving more than one million visitors per month, with investor forums held across the globe on a regular basis.

Supreme Pharmaceuticals (OTC PINK:SPRWF)(CSE:SL) said it has appointed John Fowler as the president of the company, while also electing him to the board of directors.

Fowler, previously director of operations, began working in the medical marijuana sector over 10 years ago, pursuing a career in law to assist medical marijuana patients with legal issues ancilliary to medical marijuana use.

The company said he most recently worked at a prominent Toronto law firm.

Supreme also announced it has appointed Dr. Youbin Zheng, an associate professor and environmental horticulture chair at the University of Guelph, to its advisory board. According to Supreme, he has years of experience in horticulture research, especially in vegetable and ornamental plant production in greenhouses in Canada, England, Japan and China.

The news follows Supreme's announcement last week that it is now ready for the final step prior to being approved for a production license at its Kincardine medical marijuana facility in Ontario, delivering on expectations laid out at the beginning of 2014.

The company completed the security and infrastructure upgrades at the greenhouse facility, and is ready to participate in the Health Canada pre-license inspection, though no date had yet been set as of Friday last week.

Supreme has been working steadily over the past year to develop Kincardine, and with strong support from the local community, it has been able to move quickly to implement its proposed plan since receiving the largest conditional pre-approval from Health Canada in January.

The company is planning to produce up to 24 million grams of medical marijuana at the 342,000 square foot Kincardine facility, and has had to build up the facility to meet regulatory requirements.

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.